Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Myeloid leukemia with promyelocytic features in transgenic mice expressing hCG-NuMA-RARα

Oncogene volume 23, pages 665–678 (2004)Cite this article

Abstract

Acute promyelocytic leukemia (APL) is characterized by the accumulation of abnormal promyelocytes in the bone marrow (BM), and by the presence of a reciprocal chromosomal translocation involving retinoic acid receptor alpha (RARα). To date, five RARα partner genes have been identified in APL. NuMA-RARα was identified in a pediatric case of APL carrying a translocation t(11;17)(q13;q21). Using a construct containing the NuMA-RARα fusion gene driven by the human cathepsin G promoter (hCG-NuMA-RARα), two transgenic mouse lines were generated. Transgenic mice were observed to have a genetic myeloproliferation (increased granulopoiesis in BM) at an early age, and rapidly developed a myeloproliferative disease-like myeloid leukemia. This leukemia was morphologically and immunophenotypically indistinguishable from human APL, with a penetrance of 100%. The phenotype of transgenic mice was consistent with a blockade of neutrophil differentiation. NuMA-RARα is therefore sufficient for disease development in this APL model.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Abbreviations

APL:

acute promyelocytic leukemia

ATRA:

all trans-retinoic acid

BM:

bone marrow

CFU:

colony-forming unit

LTMC:

long-term marrow culture

My/Ly:

myeloid/lymphoid

MPD:

myeloproliferative disorder

NPM :

nucleophosmin

NuMA :

nuclear mitotic apparatus

PB:

peripheral blood

PML :

promyelocytic leukemia

PLZF :

promyelocytic leukemia zinc-finger

RARα :

retinoic acid receptor alpha

References

  • Arnould C, Philippe C, Bourdon V, Gr goire MJ, Berger R and Jonveaux P . (1999). Hum. Mol. Genet., 8, 1741–1749.

  • Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR and Sultan C . (1976). Br. J. Haematol., 33, 451–458.

  • Brown D, Kogan S, Lagasse E, Weissman I, Alcalay M, Pelicci PG, Atwater S and Bishop JM . (1997). Proc. Natl. Acad. Sci. USA, 94, 2551–2556.

  • Chen G-X, Xhu X-H, Men X-O, Wang L, Huang Q-H, Jin X-L, Xiang S-M, Zhu L, Guo W-H, Chen J-Q, Xu S-F, So E, Chan L-C, Waxman S, Zelent A, Chen G-Q, Dong S, Liu J-X and Chen S-J . (1999). Proc. Natl. Acad. Sci. USA, 96, 6318–6323.

  • Chen Z, Brand NJ, Chen A, Chen S, Tong J, Wang Z, Waxman S and Zelent A . (1993). EMBO J., 12, 1161–1167.

  • Compton DA and Cleveland DW . (1993). J. Cell Biol., 120, 947–957.

  • Compton DA, Szilak I and Cleveland DW . (1992). J. Cell Biol., 116, 1395–1408.

  • David G, Terris B, Marchio A, Lavau C and Dejean A . (1997). Oncogene, 14, 1547–1554.

  • de Botton S, Chevret S, Sanz M, Donbert M, Thomas X, Guerci A, Fey M, Ragon C, Huguet F, Sotto J-J, Gardin C, Makhoul PC, Travade P, Solary E, Fegeux N, Bordessoule D, San Miguel J, Link H, Desablens B, Stamatoullas A, Deconnick E, Geiser K, Hess U, Maloisel F, Castaigne S, Preudhomme C, Chomienne C, Degos L and Fenaux P . (2000). Br. J. Hematol., 111, 801–806.

  • de Thé H, Chomienne C, Lanotte M, Degos L and Dejean A . (1990). Nature, 347, 558.

  • de Thé H, Lavau C, Marchio A, Chomienne C, Degos L and Dejean A . (1991). Cell, 66, 675.

  • Dyck JA, Maul GG, Miller Jr WH, Chen JD, Kakizuka A and Evans RM . (1994). Cell, 76, 333–343.

  • Early E, Moore MAS, Kakizuma K, Nason-Burchenal K, Martin P, Evans RM and Dmitrovsky E . (1996). Proc. Natl. Acad. Sci. USA, 93, 7900–7904.

  • Grignani F, Fagioli M, Alcalay M, Longo L, Pandolfi PP, Donti E, Biondi A, Lo Coco F and Pelicci PG . (1994). Blood, 83, 10–25.

  • Grisolano JL, Wesselschmidt RL, Pelicci PG and Ley TJ . (1997). Blood, 89, 376–387.

  • Harmon DC . (1991). The leukemias. Beck WS (ed) MIT Press: Cambridge, pp. 399–417.

  • He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A and Pandolfi PP . (1998). Nat. Genet., 18, 126–135.

  • He L-Z, Merghoub T and Pandolfi PP . (1999). Oncogene, 18, 5278–5292.

  • He LZ, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V, Cattoretti G and Pandolfi PP . (1997). Proc. Natl. Acad. Sci. USA, 94, 5302–5307.

  • Hummel JL, Wells RA, Dubé ID, Licht JD and Kamel-Reid S . (1999). Oncogene, 18, 633–641.

  • Kelly LM, Kutok JL, Williams IR, Boulton CL, Amaral SM, Curley DP, Ley TJ and Gilliland DG . (2002). Proc. Natl. Acad. Sci. USA, 99, 8283–8288.

  • Kogan SC, Brown DE, Shultz DB, Truong BT, Lallemand-Breitenbach V, Guillemin MC, Lagasse E, Weissman IL and Bishop JM . (2001). J. Exp. Med., 193, 531–543.

  • Kogan SC, Ward JM, Anver MR, Berman JJ, Brayton C, Cardiff RD, Carter JS, de Coronado S, Downing JR, Fredrickson TN, Haines DC, Harris AW, Harris NL, Hiai H, Jaffe ES, MacLennan ICM, Pandolfi PP, Pattengale PK, Perkins AS, Simpson RM, Tuttle MS, Wong JF and Morse III HC . (2002). Blood, 100, 238–245.

  • Labrecque J, Allan D, Chambon P, Iscove NN, Lohnes D and Hoang T . (1998). Blood, 92, 607–615.

  • Lane AA, Westervelt P and Ley TJ . (2002). Blood, 100, 538a.

  • Le Beau MM, Bitts S, Davis EM and Kogan SC . (2002). Blood, 99, 2985–2991.

  • Livak KJ and Schmittgen TD . (2001). Methods, 25, 402–408.

  • Mark M, Ghyselinck NB, Wendling O, Dupé V, Mascrez B, Kastner P and Chambon C . (1999). Proc. Nutr. Soc., 58, 609–613.

  • Melnick A and Licht JD . (1999). Blood, 93, 3167–3215.

  • Mu ZM, Chin KY, Liu JM, Lozano G and Chang KS . (1994). Mol. Cell. Biol., 14, 6858–6867.

  • Okubo T, Matsui N, Yanai N and Obinata M . (2000). Cell Struct. Funct., 25, 133–139.

  • Paietta E, Andersen J, Gallagher R, Bennett J, Yunis J, Cassileth P, Rowe J and Wiernik PH . (1994). Leukemia, 8, 1108–1112.

  • Pollock JL, Westervelt P, Kurichety AK, Pelicci PG, Grisolano JL and Ley TJ . (1999). Proc. Natl. Acad. Sci. USA, 96, 15103–15108.

  • Redner RL, Rush EA, Faas S, Rudert WA and Corey SJ . (1996). Blood, 87, 882–886.

  • Rego EM and Pandolfi PP . (2001). Semin. Hematol., 38, 54–70.

  • Reis PP, Rogatto SR, Kowalski LP, Nishimoto IN, Montovani JC, Corpus G, Squire JA and Kamel-Reid S . (2002). Oncogene, 21, 6480–6487.

  • Rizzatto EG, Garcia AB, Portieres FL, Silva DE, Martins SLR and Falcao FP . (2002). Am. J. Clin. Pathol., 118, 31–37.

  • Rowley JD, Golomb HM and Dougherty C . (1977a). Lancet, 1, 549–550.

  • Rowley JD, Golomb HM, Vardiman J, Fukuhara S, Dougherty C and Potter D . (1977b). Int. J. Cancer, 20, 869–872.

  • Shaknovich R, Yeyati PL, Ivins S, Melnick A, Lempert C, Waxman S, Zelent A and Licht JD . (1998). Mol. Cell. Biol., 18, 5533–5545.

  • Vickers M, Jackson G and Taylor P . (2000). Leukemia, 14, 722–726.

  • Wang ZG, Ruggero D, Ronchetti S, Zhong S, Gaboli S, Rivi R and Pandolfi PP . (1998). Nat. Genet., 20, 266–272.

  • Weir EG and Borowitz MJ . (2001). Semin. Hematol., 38, 124–138.

  • Wells RA, Catzavelos C and Kamel-Reid S . (1997). Nat. Genet., 17, 109–113.

  • Wells RA, Hummel JL, DeKoven A, Zipursky A, Kirby M, Dubé I and Kamel-Reid S . (1996). Leukemia, 10, 735–740.

  • Westerveldt P and Ley TJ . (1998). Blood, 92 (Suppl 1), 211a (abstr).

  • Zhong S, Salomoni P, Ronchetti S, Guo A, Ruggero D and Pandolfi PP . (2000). J. Exp. Med., 191, 631–640.

  • Zimonjic DB, Pollock JL, Westervelt P, Popescu NC and Ley TJ . (2000). Proc. Natl. Acad. Sci. USA, 97, 13306–13311.

Download references

Acknowledgements

We thank Dr S Arora for reading of the manuscript. This work was supported by funding from the National Cancer Institute of Canada (Grant #13087 to SK-R) and the National Institutes of Health (Grant #s R01 CA74031, R01 CA71692, and U01 CA84292 to PPP). MAS is an Ontario Graduate Scholar. We also gratefully acknowledge the disability accommodations funding provided through the University of Toronto, Office of Accessibility Services.

Author information

Authors and Affiliations

  1. Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada

    Mahadeo A Sukhai & Suzanne Kamel-Reid

  2. Department of Cellular and Molecular Biology, the Ontario Cancer Institute/University Health Network, Toronto, Ontario, Canada

    Mahadeo A Sukhai, Yali Xuan, Tong Zhang, Patricia P Reis, Karina Dubé, Denis J Bailey & Suzanne Kamel-Reid

  3. Molecular Biology Program and Department of Pathology, Molecular and Developmental Biology Lab, Memorial Sloan Kettering Cancer Center, Sloan Kettering Institute, New York, NY, USA

    Xuemei Wu, Eduardo M Rego, Mantu Bhaumik, Richard A Wells & Pier Paolo Pandolfi

  4. Department of Pathology, The Ontario Cancer Institute/University Health Network, Toronto, Ontario, Canada

    Denis J Bailey & Suzanne Kamel-Reid

  5. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada

    Suzanne Kamel-Reid

Authors
  1. Mahadeo A Sukhai
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Xuemei Wu
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Yali Xuan
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Tong Zhang
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Patricia P Reis
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. Karina Dubé
    View author publications

    You can also search for this author inPubMed Google Scholar

  7. Eduardo M Rego
    View author publications

    You can also search for this author inPubMed Google Scholar

  8. Mantu Bhaumik
    View author publications

    You can also search for this author inPubMed Google Scholar

  9. Denis J Bailey
    View author publications

    You can also search for this author inPubMed Google Scholar

  10. Richard A Wells
    View author publications

    You can also search for this author inPubMed Google Scholar

  11. Suzanne Kamel-Reid
    View author publications

    You can also search for this author inPubMed Google Scholar

  12. Pier Paolo Pandolfi
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Suzanne Kamel-Reid.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sukhai, M., Wu, X., Xuan, Y. et al. Myeloid leukemia with promyelocytic features in transgenic mice expressing hCG-NuMA-RARα. Oncogene 23, 665–678 (2004). https://doi.org/10.1038/sj.onc.1207073

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207073

Keywords

Search

Advanced search

Quick links